Kidswell Bio Corporation (4584.T)
JPY 126.0
(-0.79%)
JPY 126.0
(-0.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.43 Billion JPY | -12.43% |
| 2022 | 2.77 Billion JPY | 76.92% |
| 2021 | 1.56 Billion JPY | 57.47% |
| 2020 | 996.54 Million JPY | -7.47% |
| 2019 | 1.07 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 482.95 Million JPY | -44.13% |
| 2023 Q2 | 535.89 Million JPY | 1065.51% |
| 2023 Q1 | 45.97 Million JPY | -95.62% |
| 2023 Q4 | 864.49 Million JPY | -12.22% |
| 2023 Q3 | 984.87 Million JPY | 83.78% |
| 2023 FY | 2.43 Billion JPY | -12.43% |
| 2022 Q3 | - JPY | -100.0% |
| 2022 FY | 2.77 Billion JPY | 76.92% |
| 2022 Q4 | 1.04 Billion JPY | 0.0% |
| 2022 Q2 | 505.23 Million JPY | 0.0% |
| 2021 FY | 1.56 Billion JPY | 57.47% |
| 2020 FY | 996.54 Million JPY | -7.47% |
| 2019 FY | 1.07 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 49.032% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -2052.945% |
| GNI Group Ltd. | 26.01 Billion JPY | 90.653% |
| Linical Co., Ltd. | 12.3 Billion JPY | 80.247% |
| Trans Genic Inc. | 13.08 Billion JPY | 81.417% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -267.51% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 52.869% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -55.81% |
| AnGes, Inc. | 152.98 Million JPY | -1489.198% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -298.486% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 80.955% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -197.69% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -1694.163% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -49.533% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -467.563% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -27.879% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -256.244% |
| PeptiDream Inc. | 28.71 Billion JPY | 91.532% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -3756.777% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -1909.285% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -3376615.278% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -5995.307% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 46.099% |
| FunPep Company Limited | 530 Thousand JPY | -458623.585% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -3410.809% |
| Stella Pharma Corporation | 269.49 Million JPY | -802.158% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -667.392% |
| Cuorips Inc. | 23.1 Million JPY | -10423.916% |
| K Pharma,Inc. | 1 Billion JPY | -143.124% |
| Takara Bio Inc. | 43.5 Billion JPY | 94.412% |
| ReproCELL Incorporated | 2.42 Billion JPY | -0.182% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -41.736% |
| StemCell Institute Inc. | 2.48 Billion JPY | 2.013% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 3.299% |
| CellSeed Inc. | 190.13 Million JPY | -1178.696% |